Showing results (1-10 of 332) with videos related to
Sort By:
Pageof 34
Kidney International|December 4, 2014
Emerging treatments for amyloidosisRabya H Sayed, Philip N Hawkins, Helen J LachmannCurrent Opinion in Pharmacology|February 18, 2006
Systemic amyloidosisHelen J Lachmann, Philip N HawkinsArthritis Research & Therapy|February 24, 2009
Developments in the scientific and clinical understanding of autoinflammatory disordersHelen J Lachmann, Philip N HawkinsNephron. Clinical Practice|September 16, 2003
Novel pharmacological strategies in amyloidosisHelen J Lachmann, Philip N HawkinsEuropean Heart Journal|January 1, 2015
A study of implanted cardiac rhythm recorders in advanced cardiac AL amyloidosisRabya H Sayed, Dominic Rogers, Fakhar Khan, et al.Journal of Cardiology Cases|December 12, 2018
A case series and systematic literature review of anakinra and immunosuppression in idiopathic recurrent pericarditisIan C Scott, Vijay Hajela, Philip N Hawkins, et al.Arthritis and Rheumatism|February 12, 2004
Spectrum of clinical features in Muckle-Wells syndrome and response to anakinraPhilip N Hawkins, Helen J Lachmann, Ebun Aganna, et al.Blood|September 23, 2015
Natural history and outcome of light chain deposition diseaseRabya H Sayed, Ashutosh D Wechalekar, Janet A Gilbertson, et al.Nature Clinical Practice. Cardiovascular Medicine|December 17, 2008
Cardiac amyloidosis, a monoclonal gammopathy and a potentially misleading mutationAshutosh D Wechalekar, Mark Offer, Julian D Gillmore, et al.Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|July 27, 2017
Safety and efficacy of empirical interleukin-1 inhibition using anakinra in AA amyloidosis of uncertain aetiologyThirusha Lane, Ashutosh D Wechalekar, Julian D Gillmore, et al.Pageof 34